- MRNA +1.73%
Myocarditis risks from Covid-19 vaccines are still less than the risks from Covid-19
Yahoo Finance · 5 days ago
Open | 82.35 |
High | 84.28 |
Low | 81.25 |
Mkt Cap | 31.69B |
P/E (TTM) | N/A |
Div & Yield | N/A & N/A |
Prev. Close | 81.04 |
52 Wk. Low | 62.55 |
52 Wk. High | 170.47 |
Related stocks
American biotechnology company
Moderna, Inc. is an American pharmaceutical and biotechnology company based in Cambridge, Massachusetts, that focuses on RNA therapeutics, primarily mRNA vaccines. Wikipedia
(USD) | Q2 2024 | Y/Y |
---|---|---|
Revenue | 241M | 29.90% ▼ |
Net Income | -1.28B | - |
Diluted EPS | -3.33 | - |
Quarter | EPS Estimate | EPS Actual |
---|---|---|
Q3 2024 | -$1.70 | - |
Q2 2024 | -$3.38 | -$3.33 |
Q1 2024 | -$3.58 | -$3.07 |
S&P 500^GSPC | 5,634.61+63.97 (+1.15%) |
Dow 30^DJI | 41,175.08+462.28 (+1.14%) |
Nasdaq^IXIC | 17,877.79+258.44 (+1.47%) |
129.37+4.55% | |
209.98-0.07% | |
117.56+2.49% |